Cancer Family
Reproductive System Neoplasm
CI-CAN-00000338Explore in graph →
Non-malignant3,042 active trials38 approved drugs197 evidence items
- NCIt
- C3674
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000338Explore in graph →
Clinical trials
13,672 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05335993 | A Clinical Study Evaluating a Combination of Oregovomab and Niraparib in Adult Women With Platinum Sensitive Recurrent Ovarian Cancer. | active not recruiting | Phase 2 | 10 | CanariaBio Inc.INDUSTRY | 1 | Apr 3, 2026 | clinicaltrials |
| NCT04893434 | Novel Imaging Technique to Assess Gynecologic Cancer | active not recruiting | Phase 1 | 24 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 2, 2026 | clinicaltrials |
| NCT06342986 | Intraperitoneal FT536 in Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer | active not recruiting | Phase 1 | 3 | Masonic Cancer Center, University of MinnesotaOTHER | 1 | Apr 2, 2026 | clinicaltrials |
| NCT02873962 | A Phase II Study Of Nivolumab/ Bevacizumab/Rucaparib | active not recruiting | Phase 2 | 72 | Dana-Farber Cancer InstituteOTHER | 1 | Apr 1, 2026 | clinicaltrials |
| NCT03614949 | SBRT and Atezolizumab in the Management of Recurrent, Persistent, or Metastatic Cervical Cancer | active not recruiting | Phase 2 | 21 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Apr 1, 2026 | clinicaltrials |
| NCT04300855 | Clinical Trial of Green Tea Catechins in Men on Active Surveillance | active not recruiting | Phase 2 | 115 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Apr 1, 2026 | clinicaltrials |
| NCT04498117 | Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery(FLORA-5) | active not recruiting | Phase 3 | 615 | CanariaBio Inc.INDUSTRY | 14 | Apr 1, 2026 | clinicaltrials |
| NCT05605535 | Oregovomab Plus Chemotherapy in Neo-adjuvant Setting in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer | active not recruiting | Phase 2 | 88 | CanariaBio Inc.INDUSTRY | 1 | Apr 1, 2026 | clinicaltrials |
| NCT05645146 | Enhancing Long-Term Smoking Abstinence Among Cervical Cancer Survivors (Project ACCESS) | active not recruiting | N/A | 360 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Apr 1, 2026 | clinicaltrials |
| NCT01977274 | Predictive Clinical and Biological Parameters in Gynecological Cancer(GC-BIO) | active not recruiting | N/A | 300 | Institut Paoli-CalmettesOTHER | 1 | Mar 31, 2026 | clinicaltrials |
| NCT04357925 | Quality of Life in Prostate Cancer Patients(QoLProstateMQ) | active not recruiting | — | 304 | University Hospital Center of MartiniqueOTHER | 1 | Mar 31, 2026 | clinicaltrials |
| NCT05266313 | Contributions of a Paramedical Approach in the Prevention and Treatment of Side Effects Associated With Radical Prostatectomy(VITALITE) | active not recruiting | N/A | 135 | University Hospital Center of MartiniqueOTHER | 1 | Mar 31, 2026 | clinicaltrials |
| NCT03471650 | Study of PSMA-targeted 18F-DCFPyL PET/CT for the Detection of Clinically Significant Prostate Cancer | active not recruiting | Phase 2 | 150 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Mar 30, 2026 | clinicaltrials |
| NCT03860272 | Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer | active not recruiting | Phase 1 | 499 | Agenus Inc.INDUSTRY | 2 | Mar 30, 2026 | clinicaltrials |
| NCT05514028 | Evaluation of Salivary RNAs in the Presence of an Adnexal Mass of Ovarian Origin(OVAmiARN) | active not recruiting | — | 746 | ZIWIGINDUSTRY | 3 | Mar 30, 2026 | clinicaltrials |
| NCT00587886 | Estrogen, Diet, Genetics and Endometrial Cancer | active not recruiting | — | 1,315 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 27, 2026 | clinicaltrials |
| NCT04663997 | 177 LuPSMA-617 vs Docetaxel in Metastatic Castration Resistant and PSMA-Positive Prostate Cancer | active not recruiting | Phase 2 | 200 | Canadian Cancer Trials GroupNETWORK | 1 | Mar 27, 2026 | clinicaltrials |
| NCT05870761 | Combination Niraparib and Dostarlimab Therapy for Recurrent or Persistent Uterine Serous Carcinoma | active not recruiting | Phase 2 | 8 | Casey CosgroveOTHER | 1 | Mar 27, 2026 | clinicaltrials |
| NCT05678322 | Optimizing Timing of rhPSMA-7.3 (18F) for Assessing Site(s) of Recurrent Disease Following Radical Prostatectomy | active not recruiting | Phase 3 | 26 | NYU Langone HealthOTHER | 1 | Mar 25, 2026 | clinicaltrials |
| NCT04008797 | A Study of E7386 in Combination With Other Anticancer Drug(s) in Participants With Solid Tumor | active not recruiting | Phase 1 / Phase 2 | 301 | Eisai Inc.INDUSTRY | 10 | Mar 24, 2026 | clinicaltrials |
| NCT04095364 | Letrozole With or Without Paclitaxel and Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | active not recruiting | Phase 3 | 450 | NRG OncologyOTHER | 6 | Mar 24, 2026 | clinicaltrials |
| NCT01441687 | Comparing the Reliability of Expressed Prostatic Secretion (EPS) and Post Massage Urine (PMU) for the Prediction of Prostate Cancer Biopsy Outcome | active not recruiting | N/A | 243 | City of Hope Medical CenterOTHER | 1 | Mar 23, 2026 | clinicaltrials |
| NCT02722525 | Cardiac MRI in Measuring the Impact of Anti-androgen Treatment on Cardiac Function in Patients With Prostate Cancer | active not recruiting | N/A | 23 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Mar 23, 2026 | clinicaltrials |
| NCT03787680 | Targeting Resistant Prostate Cancer With ATR and PARP Inhibition (TRAP Trial) | active not recruiting | Phase 2 | 49 | University of Michigan Rogel Cancer CenterOTHER | 1 | Mar 23, 2026 | clinicaltrials |
| NCT05096338 | Mechanisms, Predictors, and Social Determinants of Cardiotoxicity in Prostate Cancer(PCT) | active not recruiting | — | 200 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Mar 23, 2026 | clinicaltrials |
| NCT05658003 | A Study Evaluating [177Lu]Lu-PSMA-617 vs. a Change of Androgen Receptor-directed Therapy in Taxane Treatment Naive Chinese Male Patients With Progressive Metastatic Castrate Resistant Prostate Cancer | active not recruiting | Phase 2 | 63 | Novartis PharmaceuticalsINDUSTRY | 1 | Mar 23, 2026 | clinicaltrials |
| NCT05980169 | The Effect of Low Frequency Soundwave Stimulation on Chemotherapy Induced Peripheral Neuropathy | active not recruiting | N/A | 80 | Augusta UniversityOTHER | 1 | Mar 23, 2026 | clinicaltrials |
| NCT06018311 | Hispanic Adapted and Culturally Relevant Exercising Together(HACER) | active not recruiting | N/A | 58 | University of ArizonaOTHER | 1 | Mar 20, 2026 | clinicaltrials |
| NCT06126172 | Radiomics of Treatment-naive Prostate Cancer Patients on Multiparametric MRI for Risk Stratification and Treatment Outcomes Predictions | active not recruiting | N/A | 125 | Chang Gung Memorial HospitalOTHER | 1 | Mar 20, 2026 | clinicaltrials |
| NCT07486622 | Transvaginal Electromechanical Fragmentation and Removal of Large Uterus in a Sealed Bag: The First Group of Clinical Studies Balancing Scar - Free and Anti - Dissemination | active not recruiting | — | 25 | Chang ZhouOTHER | 1 | Mar 20, 2026 | clinicaltrials |
| NCT03412396 | Apalutamide in Treating Patients With Prostate Cancer Before Radical Prostatectomy | active not recruiting | Phase 2 | 45 | M.D. Anderson Cancer CenterOTHER | 1 | Mar 19, 2026 | clinicaltrials |
| NCT04262609 | Faecal Incontinence in Prostate Cancer Survivors Treated Whith Radiotherapy | active not recruiting | — | 200 | Consorci Sanitari de TerrassaOTHER | 1 | Mar 19, 2026 | clinicaltrials |
| NCT03663218 | PRE-ProstAtectomy MRI-GuidEd Stereotactic Body RadioTherapy for High-Risk Prostate Cancer Trial (PREPARE SBRT)(PREPARE SBRT) | active not recruiting | N/A | 16 | Weill Medical College of Cornell UniversityOTHER | 1 | Mar 18, 2026 | clinicaltrials |
| NCT05343936 | Evaluation of an Active Surveillance Protocol for Prostate Cancer in the Brazilian Population | active not recruiting | — | 490 | Hospital Moinhos de VentoOTHER | 1 | Mar 18, 2026 | clinicaltrials |
| NCT06307704 | Lung US for PEEP Optimization in Robotic Radical Prostatectomy or Cystectomy Patients | active not recruiting | N/A | 88 | Nazmy Edward SeifOTHER | 1 | Mar 18, 2026 | clinicaltrials |
| NCT06408597 | Mannitol Versus Nitroglycerin for Kidney Injury Prevention in Robotic-assisted Radical Prostatectomy or Cystectomy | active not recruiting | N/A | 90 | Nazmy Edward SeifOTHER | 1 | Mar 18, 2026 | clinicaltrials |
| NCT06810427 | A Novel, Low-Cost, Handheld 3D Imaging System for Improved Screening for Cervical Neoplasia in Resource-Limited Settings(CervImage) | active not recruiting | N/A | 18 | Carilion ClinicOTHER | 1 | Mar 18, 2026 | clinicaltrials |
| NCT05245006 | PET Imaging Study of 89Zr-DFO-YS5 in Men With Prostate Cancer | active not recruiting | Phase 1 | 30 | Robert Flavell, MD, PhDOTHER | 1 | Mar 17, 2026 | clinicaltrials |
| NCT03519230 | Maintenance Treatment With BGB-290 Versus Placebo in Participants With Platinum-sensitive Recurrent Ovarian Cancer | active not recruiting | Phase 3 | 224 | BeiGeneINDUSTRY | 1 | Mar 16, 2026 | clinicaltrials |
| NCT03842982 | Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer (CHIPPI)(CHIPPI) | active not recruiting | Phase 3 | 362 | Centre Oscar LambretOTHER | 2 | Mar 16, 2026 | clinicaltrials |
| NCT06286462 | Evaluation of the Cancer Tracking System (CATSystem)(CATSystem) | active not recruiting | N/A | 6,600 | University of Kansas Medical CenterOTHER | 1 | Mar 16, 2026 | clinicaltrials |
| NCT07474688 | Laparoscopic Myomectomy Based on a Fully Enclosed Protective Device: A Novel Surgical Technique Achieving Tumor-Free Protection Throughout the Entire Procedure | active not recruiting | — | 20 | China-Japan Friendship HospitalOTHER | 1 | Mar 16, 2026 | clinicaltrials |
| NCT04435756 | A Study of miRNA 371 in Patients With Germ Cell Tumors | active not recruiting | — | 956 | SWOG Cancer Research NetworkNETWORK | 3 | Mar 12, 2026 | clinicaltrials |
| NCT05763199 | Standardized Extract of Cultured Lentinula Edodes Mycelia (AHCC®) in Ovarian Cancer Patients on Adjuvant Chemotherapy | active not recruiting | Phase 2 | 20 | University of California, DavisOTHER | 1 | Mar 12, 2026 | clinicaltrials |
| NCT02655016 | A Study of Niraparib (GSK3985771) Maintenance Treatment in Participants With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy | active not recruiting | Phase 3 | 733 | Tesaro, Inc.INDUSTRY | 14 | Mar 10, 2026 | clinicaltrials |
| NCT03875820 | Phase I Trial of Defactinib and VS-6766.(FRAME) | active not recruiting | Phase 1 | 87 | Institute of Cancer Research, United KingdomOTHER | 1 | Mar 10, 2026 | clinicaltrials |
| NCT04845503 | Stereotactic MRI-guided Radiation Therapy for Localized prostatE Cancer(SMILE) | active not recruiting | N/A | 68 | University Hospital HeidelbergOTHER | 1 | Mar 10, 2026 | clinicaltrials |
| NCT05824468 | Zimberelimab Plus Lenvatinib After Progression on Prior Immune Checkpoint Inhibitors for Advanced Cervical Cancer | active not recruiting | Phase 2 | 30 | Sun Yat-sen UniversityOTHER | 1 | Mar 10, 2026 | clinicaltrials |
| NCT05824481 | Study of Cadonilimab (AK104) Plus Lenvatinib in Patients With Advanced Endometrial Cancer | active not recruiting | Phase 2 | 32 | Sun Yat-sen UniversityOTHER | 1 | Mar 10, 2026 | clinicaltrials |
| NCT00578240 | Molecular Studies and Clinical Correlations in Human Prostatic Disease | active not recruiting | — | 5,290 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 9, 2026 | clinicaltrials |
Data updated 23 days agoSource updated Apr 3, 2026source: clinicaltrials